+91-22-489139092019 ലെ മികച്ച ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
ഇക്വിറ്റി ഫണ്ടുകൾ വിവിധ കമ്പനികളുടെ ഇക്വിറ്റി, ഇക്വിറ്റി സംബന്ധിയായ ഉപകരണങ്ങളിൽ നിക്ഷേപിച്ച ഫണ്ട് പണം നിക്ഷേപിക്കുന്നവരാണ്. മിതമായതും ഉയർന്നതുമായ ആളുകൾക്ക് ദീർഘകാല നിക്ഷേപ ഓപ്ഷനായി ഇക്വിറ്റി ഫണ്ടുകൾ കണക്കാക്കപ്പെടുന്നുഅപകടസാധ്യത വിശപ്പ്. ഇക്വിറ്റി ഫണ്ടുകളുടെ വിവിധ വിഭാഗങ്ങൾ ഉൾപ്പെടുന്നുവലിയ ക്യാപ് ഫണ്ടുകൾ,മിഡ് ക്യാപ് ഫണ്ടുകൾ,ചെറിയ ക്യാപ് ഫണ്ടുകൾ,ELSS, ഇത്യാദി. 2019 ൽ, ഇക്വിറ്റി മാർക്കറ്റുകളിൽ ഒരു ഉയർച്ചയുണ്ടായി, ഇക്വിറ്റി ഫണ്ട് വിഭാഗങ്ങളിൽ ഭൂരിഭാഗവും മികച്ച പ്രകടനം കാഴ്ചവച്ചു. ഈ ഫണ്ടുകളുടെ പ്രകടനം വ്യവസായ പ്രകടനം, കമ്പനി പ്രകടനം, കമ്പനികളുടെ വരുമാനവും ലാഭവും, അതിന്റെ ഭാവി സാധ്യതകൾ തുടങ്ങിയ നിരവധി മാക്രോ, മൈക്രോ ഇക്കണോമിക് പാരാമീറ്ററുകളെ ആശ്രയിച്ചിരിക്കുന്നു. മുകളിലുംമികച്ച ഇക്വിറ്റി ഫണ്ടുകൾ 2019 വർഷത്തിൽ ഇനിപ്പറയുന്നവയാണ്.
Talk to our investment specialist
പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹99.9717
↑ 1.24 ₹34,780 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹49.5068
↑ 0.45 ₹995 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹51.6522
↑ 0.40 ₹4,223 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹60.4365
↑ 0.61 ₹13,679 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹178.56
↑ 1.40 ₹8,062 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹287.291
↑ 2.98 ₹1,119 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹420.149
↑ 0.77 ₹3,963 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.2306
↑ 0.23 ₹1,309 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹30.4687
↑ 0.44 ₹604 40 33.4 2.4 64.7 19 Bandhan Infrastructure Fund Growth ₹49.415
↑ 0.34 ₹1,613 39.3 50.3 1.7 64.8 6.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 1 Oct 25 Research Highlights & Commentary of 10 Funds showcased
Commentary Motilal Oswal Midcap 30 Fund LIC MF Infrastructure Fund Motilal Oswal Long Term Equity Fund Motilal Oswal Multicap 35 Fund Invesco India Mid Cap Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund IDBI Small Cap Fund Bandhan Infrastructure Fund Point 1 Highest AUM (₹34,780 Cr). Bottom quartile AUM (₹995 Cr). Upper mid AUM (₹4,223 Cr). Top quartile AUM (₹13,679 Cr). Upper mid AUM (₹8,062 Cr). Bottom quartile AUM (₹1,119 Cr). Upper mid AUM (₹3,963 Cr). Lower mid AUM (₹1,309 Cr). Bottom quartile AUM (₹604 Cr). Lower mid AUM (₹1,613 Cr). Point 2 Established history (11+ yrs). Established history (17+ yrs). Established history (10+ yrs). Established history (11+ yrs). Established history (18+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (8+ yrs). Established history (14+ yrs). Point 3 Rating: 3★ (upper mid). Not Rated. Not Rated. Top rated. Rating: 2★ (upper mid). Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Not Rated. Rating: 5★ (top quartile). Point 4 Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Point 5 5Y return: 31.70% (upper mid). 5Y return: 31.74% (top quartile). 5Y return: 25.67% (lower mid). 5Y return: 18.87% (lower mid). 5Y return: 27.01% (upper mid). 5Y return: 17.16% (bottom quartile). 5Y return: 18.78% (bottom quartile). 5Y return: 17.23% (bottom quartile). 5Y return: 27.28% (upper mid). 5Y return: 33.12% (top quartile). Point 6 3Y return: 24.57% (upper mid). 3Y return: 27.90% (top quartile). 3Y return: 25.61% (upper mid). 3Y return: 21.28% (bottom quartile). 3Y return: 26.99% (top quartile). 3Y return: 24.16% (lower mid). 3Y return: 24.51% (lower mid). 3Y return: 21.98% (bottom quartile). 3Y return: 17.99% (bottom quartile). 3Y return: 26.88% (upper mid). Point 7 1Y return: -8.03% (bottom quartile). 1Y return: -5.22% (lower mid). 1Y return: -5.65% (lower mid). 1Y return: -5.19% (upper mid). 1Y return: 3.57% (top quartile). 1Y return: -1.24% (upper mid). 1Y return: 0.14% (top quartile). 1Y return: -2.95% (upper mid). 1Y return: -11.03% (bottom quartile). 1Y return: -12.29% (bottom quartile). Point 8 Alpha: 4.99 (upper mid). Alpha: -1.71 (bottom quartile). Alpha: 7.18 (top quartile). Alpha: 9.76 (top quartile). Alpha: 0.00 (lower mid). Alpha: 0.79 (lower mid). Alpha: 2.04 (upper mid). Alpha: 3.78 (upper mid). Alpha: -4.61 (bottom quartile). Alpha: 0.00 (bottom quartile). Point 9 Sharpe: -0.18 (upper mid). Sharpe: -0.46 (bottom quartile). Sharpe: -0.26 (lower mid). Sharpe: -0.06 (upper mid). Sharpe: 0.14 (top quartile). Sharpe: -0.15 (upper mid). Sharpe: -0.05 (top quartile). Sharpe: -0.39 (lower mid). Sharpe: -0.70 (bottom quartile). Sharpe: -0.71 (bottom quartile). Point 10 Information ratio: 0.57 (upper mid). Information ratio: 0.34 (lower mid). Information ratio: 0.80 (top quartile). Information ratio: 0.79 (top quartile). Information ratio: 0.00 (bottom quartile). Information ratio: 0.10 (lower mid). Information ratio: 0.38 (upper mid). Information ratio: 0.78 (upper mid). Information ratio: -0.82 (bottom quartile). Information ratio: 0.00 (bottom quartile). Motilal Oswal Midcap 30 Fund
LIC MF Infrastructure Fund
Motilal Oswal Long Term Equity Fund
Motilal Oswal Multicap 35 Fund
Invesco India Mid Cap Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
IDBI Small Cap Fund
Bandhan Infrastructure Fund
2019 ലെ മികച്ചതും മികച്ചതുമായ ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Research Highlights for LIC MF Infrastructure Fund Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Long Term Equity Fund Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Multicap 35 Fund Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Research Highlights for Invesco India Mid Cap Fund Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI Small Cap Fund Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (01 Oct 25) ₹99.9717 ↑ 1.24 (1.25 %) Net Assets (Cr) ₹34,780 on 31 Aug 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.56 Sharpe Ratio -0.18 Information Ratio 0.57 Alpha Ratio 4.99 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹16,771 30 Sep 22 ₹20,631 30 Sep 23 ₹24,973 30 Sep 24 ₹42,904 30 Sep 25 ₹39,390 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -4.4% 3 Month -4.5% 6 Month 9.4% 1 Year -8% 3 Year 24.6% 5 Year 31.7% 10 Year 15 Year Since launch 22% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.92 Yr. Niket Shah 1 Jul 20 5.17 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Sunil Sawant 1 Jul 24 1.17 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Technology 37.96% Consumer Cyclical 26.86% Industrials 20.24% Communication Services 3.34% Health Care 3.21% Financial Services 3.2% Real Estate 2.58% Asset Allocation
Asset Class Value Cash 2.61% Equity 97.39% Top Securities Holdings / Portfolio
Name Holding Value Quantity Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON10% ₹3,505 Cr 2,099,999 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹3,405 Cr 19,750,000
↑ 1,749,950 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | TRENT9% ₹3,179 Cr 6,000,000
↑ 750,000 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 25 | 5433209% ₹3,140 Cr 100,000,000
↑ 100,000,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL9% ₹3,025 Cr 60,000,000
↑ 9,923,760 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433969% ₹3,018 Cr 25,000,000
↑ 11,130,003 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT8% ₹2,918 Cr 5,500,000
↑ 99,995 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB6% ₹2,163 Cr 3,050,000
↑ 300,000 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI4% ₹1,429 Cr 3,750,000
↑ 250,000 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 25 | KAYNES4% ₹1,286 Cr 2,100,000
↑ 153,298 2. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (01 Oct 25) ₹49.5068 ↑ 0.45 (0.92 %) Net Assets (Cr) ₹995 on 31 Aug 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.47 Information Ratio 0.34 Alpha Ratio -1.71 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹17,349 30 Sep 22 ₹19,152 30 Sep 23 ₹24,311 30 Sep 24 ₹42,112 30 Sep 25 ₹39,703 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month 3.2% 3 Month -2.5% 6 Month 14.2% 1 Year -5.2% 3 Year 27.9% 5 Year 31.7% 10 Year 15 Year Since launch 9.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.96 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for LIC MF Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 50.96% Basic Materials 9.62% Financial Services 7.78% Consumer Cyclical 6.93% Utility 5.82% Technology 4.2% Health Care 4.07% Real Estate 3.47% Communication Services 2.94% Energy 0.9% Asset Allocation
Asset Class Value Cash 3.31% Equity 96.69% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP6% ₹56 Cr 693,857 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹39 Cr 109,584 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP4% ₹36 Cr 46,843 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹32 Cr 769,765 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD3% ₹32 Cr 911,009 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹27 Cr 319,302 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹26 Cr 310,615 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND3% ₹26 Cr 67,407 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹25 Cr 94,287 Mahindra Lifespace Developers Ltd (Real Estate)
Equity, Since 30 Jun 24 | MAHLIFE2% ₹23 Cr 666,245 3. Motilal Oswal Long Term Equity Fund
Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (01 Oct 25) ₹51.6522 ↑ 0.40 (0.78 %) Net Assets (Cr) ₹4,223 on 31 Aug 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 1.65 Sharpe Ratio -0.26 Information Ratio 0.8 Alpha Ratio 7.18 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹16,651 30 Sep 22 ₹16,046 30 Sep 23 ₹20,191 30 Sep 24 ₹33,630 30 Sep 25 ₹31,553 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month 2% 3 Month -3.3% 6 Month 15% 1 Year -5.6% 3 Year 25.6% 5 Year 25.7% 10 Year 15 Year Since launch 16.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.73 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Atul Mehra 1 Oct 24 0.92 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 31.75% Financial Services 18.72% Consumer Cyclical 18.07% Technology 13.51% Basic Materials 5.57% Real Estate 4.35% Health Care 3.36% Communication Services 1.59% Consumer Defensive 1.34% Asset Allocation
Asset Class Value Cash 1.75% Equity 98.25% Top Securities Holdings / Portfolio
Name Holding Value Quantity Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433207% ₹282 Cr 8,970,581 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX5% ₹192 Cr 259,208
↑ 10,770 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹184 Cr 1,176,224
↓ -55,632 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹177 Cr 289,593 Waaree Energies Ltd (Technology)
Equity, Since 31 Oct 24 | 5442774% ₹176 Cr 516,106
↑ 29,061 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹175 Cr 240,350 One97 Communications Ltd (Technology)
Equity, Since 30 Jun 25 | 5433964% ₹152 Cr 1,256,967
↑ 285,421 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL3% ₹147 Cr 1,022,957
↓ -33,358 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM3% ₹147 Cr 430,073 Piramal Enterprises Ltd (Financial Services)
Equity, Since 31 Jul 24 | PEL3% ₹143 Cr 1,279,233
↑ 110,849 4. Motilal Oswal Multicap 35 Fund
Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (01 Oct 25) ₹60.4365 ↑ 0.61 (1.02 %) Net Assets (Cr) ₹13,679 on 31 Aug 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 1.77 Sharpe Ratio -0.06 Information Ratio 0.79 Alpha Ratio 9.76 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹14,224 30 Sep 22 ₹13,477 30 Sep 23 ₹15,455 30 Sep 24 ₹25,165 30 Sep 25 ₹23,797 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -3.4% 3 Month -4.8% 6 Month 7.5% 1 Year -5.2% 3 Year 21.3% 5 Year 18.9% 10 Year 15 Year Since launch 17% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.92 Yr. Niket Shah 1 Jul 22 3.17 Yr. Rakesh Shetty 22 Nov 22 2.78 Yr. Atul Mehra 1 Oct 24 0.92 Yr. Sunil Sawant 1 Jul 24 1.17 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Technology 32.01% Consumer Cyclical 25.1% Industrials 20.77% Financial Services 9.8% Utility 6.17% Communication Services 2.9% Health Care 1.69% Asset Allocation
Asset Class Value Cash 1.57% Equity 98.43% Top Securities Holdings / Portfolio
Name Holding Value Quantity Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB10% ₹1,418 Cr 2,000,000 Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE10% ₹1,379 Cr 8,000,000
↓ -5,911 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 25 | DIXON10% ₹1,335 Cr 800,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT10% ₹1,326 Cr 2,500,000
↑ 200,000 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | TRENT10% ₹1,325 Cr 2,500,000
↑ 500,000 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 May 25 | 5433208% ₹1,099 Cr 35,000,000
↑ 32,866,603 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL7% ₹1,008 Cr 20,000,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | CGPOWER6% ₹868 Cr 12,500,000
↓ -999,862 Siemens Energy India Ltd (Utilities)
Equity, Since 30 Jun 25 | ENRIN6% ₹844 Cr 2,500,000 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN6% ₹835 Cr 5,877,500
↑ 877,500 5. Invesco India Mid Cap Fund
Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (01 Oct 25) ₹178.56 ↑ 1.40 (0.79 %) Net Assets (Cr) ₹8,062 on 31 Aug 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.82 Sharpe Ratio 0.14 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹15,993 30 Sep 22 ₹16,218 30 Sep 23 ₹20,052 30 Sep 24 ₹32,068 30 Sep 25 ₹32,954 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -0.6% 3 Month -1.4% 6 Month 17.7% 1 Year 3.6% 3 Year 27% 5 Year 27% 10 Year 15 Year Since launch 16.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.81 Yr. Amit Ganatra 1 Sep 23 2 Yr. Data below for Invesco India Mid Cap Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Financial Services 30.14% Health Care 18.68% Consumer Cyclical 17.28% Industrials 11.33% Real Estate 7.58% Technology 7.55% Basic Materials 5.07% Communication Services 1.53% Asset Allocation
Asset Class Value Cash 0.84% Equity 99.16% Top Securities Holdings / Portfolio
Name Holding Value Quantity Swiggy Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | SWIGGY5% ₹400 Cr 9,763,728
↑ 1,008,324 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF5% ₹366 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE4% ₹340 Cr 2,179,545
↑ 147,923 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | MFSL4% ₹325 Cr 2,031,299
↑ 14,403 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹323 Cr 1,676,417 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹322 Cr 463,277 BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE4% ₹318 Cr 1,519,233 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | TRENT4% ₹309 Cr 583,431
↑ 142,280 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK3% ₹280 Cr 14,592,638 AU Small Finance Bank Ltd (Financial Services)
Equity, Since 31 Jul 25 | AUBANK3% ₹280 Cr 3,893,254
↑ 2,304,000 6. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (01 Oct 25) ₹287.291 ↑ 2.98 (1.05 %) Net Assets (Cr) ₹1,119 on 31 Aug 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio -0.15 Information Ratio 0.1 Alpha Ratio 0.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,129 30 Sep 22 ₹11,561 30 Sep 23 ₹14,305 30 Sep 24 ₹22,319 30 Sep 25 ₹21,898 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -0.5% 3 Month 0.8% 6 Month 8.6% 1 Year -1.2% 3 Year 24.2% 5 Year 17.2% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.34 Yr. Data below for UTI Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 98.23% Basic Materials 1.12% Asset Allocation
Asset Class Value Cash 0.65% Equity 99.35% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA9% ₹105 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹64 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM5% ₹60 Cr 242,673
↑ 42,673 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | LUPIN5% ₹51 Cr 270,000
↑ 15,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹45 Cr 360,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹45 Cr 70,039
↓ -10,244 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS4% ₹42 Cr 465,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹42 Cr 220,000
↑ 30,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹40 Cr 53,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹38 Cr 72,000
↑ 17,000 7. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (30 Sep 25) ₹420.149 ↑ 0.77 (0.18 %) Net Assets (Cr) ₹3,963 on 31 Aug 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.05 Information Ratio 0.38 Alpha Ratio 2.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,138 30 Sep 22 ₹12,251 30 Sep 23 ₹15,800 30 Sep 24 ₹23,614 30 Sep 25 ₹23,646 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -1.7% 3 Month -2.8% 6 Month 2.2% 1 Year 0.1% 3 Year 24.5% 5 Year 18.8% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.26 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 90.36% Basic Materials 5.79% Asset Allocation
Asset Class Value Cash 3.85% Equity 96.15% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹431 Cr 2,700,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹270 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | 5432206% ₹242 Cr 2,100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA5% ₹191 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A4% ₹168 Cr 270,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN4% ₹159 Cr 840,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARM4% ₹142 Cr 400,000
↑ 80,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND3% ₹138 Cr 560,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS3% ₹137 Cr 1,500,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹131 Cr 700,000 8. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (01 Oct 25) ₹30.2306 ↑ 0.23 (0.78 %) Net Assets (Cr) ₹1,309 on 31 Aug 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio -0.39 Information Ratio 0.78 Alpha Ratio 3.78 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,118 30 Sep 22 ₹12,243 30 Sep 23 ₹14,936 30 Sep 24 ₹22,907 30 Sep 25 ₹22,051 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month -0.6% 3 Month 0.5% 6 Month 6.7% 1 Year -3% 3 Year 22% 5 Year 17.2% 10 Year 15 Year Since launch 12% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.96 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 94.45% Financial Services 1.56% Basic Materials 1.44% Asset Allocation
Asset Class Value Cash 2.56% Equity 97.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA10% ₹130 Cr 815,483
↓ -40,979 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA7% ₹91 Cr 569,903 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP5% ₹67 Cr 88,528
↓ -4,298 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG5% ₹63 Cr 942,453 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN5% ₹63 Cr 330,887 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARM5% ₹60 Cr 168,394
↑ 13,677 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹58 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM4% ₹56 Cr 106,435 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | 5432204% ₹53 Cr 458,724
↑ 50,807 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB4% ₹51 Cr 83,315
↑ 21,175 9. IDBI Small Cap Fund
IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (01 Oct 25) ₹30.4687 ↑ 0.44 (1.46 %) Net Assets (Cr) ₹604 on 31 Aug 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.7 Information Ratio -0.82 Alpha Ratio -4.61 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹18,099 30 Sep 22 ₹20,385 30 Sep 23 ₹24,177 30 Sep 24 ₹37,333 30 Sep 25 ₹33,001 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month 2.4% 3 Month -0.4% 6 Month 9.5% 1 Year -11% 3 Year 18% 5 Year 27.3% 10 Year 15 Year Since launch 14.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 1.17 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for IDBI Small Cap Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 32.4% Basic Materials 13.71% Consumer Cyclical 12.58% Consumer Defensive 7.42% Financial Services 6.62% Technology 6.3% Utility 5.99% Health Care 5.53% Communication Services 1.75% Asset Allocation
Asset Class Value Cash 7.72% Equity 92.29% Top Securities Holdings / Portfolio
Name Holding Value Quantity Apollo Micro Systems Ltd Ordinary Shares (Industrials)
Equity, Since 30 Jun 25 | 5408793% ₹21 Cr 877,192 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL3% ₹16 Cr 326,140 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419742% ₹15 Cr 109,106 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER2% ₹15 Cr 270,441 JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346002% ₹14 Cr 1,958,225
↓ -165,804 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO2% ₹14 Cr 668,754 Syrma SGS Technology Ltd (Technology)
Equity, Since 31 May 25 | SYRMA2% ₹14 Cr 180,780 Arvind Fashions Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | ARVINDFASN2% ₹13 Cr 259,739 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹13 Cr 1,130,075 Exide Industries Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | EXIDEIND2% ₹13 Cr 321,398 10. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (01 Oct 25) ₹49.415 ↑ 0.34 (0.70 %) Net Assets (Cr) ₹1,613 on 31 Aug 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.71 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹20,085 30 Sep 22 ₹20,588 30 Sep 23 ₹27,745 30 Sep 24 ₹47,816 30 Sep 25 ₹41,763 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Oct 25 Duration Returns 1 Month 0.6% 3 Month -5.1% 6 Month 7.7% 1 Year -12.3% 3 Year 26.9% 5 Year 33.1% 10 Year 15 Year Since launch 11.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.6 Yr. Ritika Behera 7 Oct 23 1.9 Yr. Gaurav Satra 7 Jun 24 1.24 Yr. Data below for Bandhan Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 53.39% Utility 12.18% Basic Materials 7.23% Communication Services 4.6% Energy 3.81% Financial Services 3.12% Health Care 2.24% Technology 2.22% Consumer Cyclical 1.38% Real Estate 1.2% Asset Allocation
Asset Class Value Cash 8.64% Equity 91.36% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹84 Cr 433,186
↓ -10,199 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT5% ₹74 Cr 206,262 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | ULTRACEMCO4% ₹63 Cr 49,772 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹62 Cr 330,018 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹61 Cr 452,706 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹53 Cr 1,431,700 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA3% ₹53 Cr 4,733,244 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹48 Cr 365,137 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Aug 24 | INDIGO3% ₹47 Cr 83,887
↑ 34,446 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹47 Cr 12,400,122
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for Motilal Oswal Midcap 30 Fund